Regeneron’s Kevzara May be Able to Reduce Deaths from COVID-19 Infections Now!!
Why Kevzara Might Reduce Deaths from COVID-19 Kevzara (sarilumab) was developed by Regeneron and Sanofi as a human monoclonal antibody against the interleukin-6 (IL-6) receptor. It was initially approved for the treatment of rheumatoid arthritis (RA) in the US in May 2017 and the EU in June 2017. IL-6 a powerful pro-inflammatory cytokine that when […]
